
May 16, 2025, 07:27
Can Ablative Therapy Play a Role in Treating Residual Disease in Stage IV NSCLC?
The International Association for the Study of Lung Cancer (IASLC) shared a post on X:
“Can ablative therapy play a role in treating residual disease in stage IV NSCLC? On Lung Cancer Considered,
Stephen V Liu joins Mara Antonoff, Shankar Siva and David Carbone to discuss a complex case and evolving treatment strategies.Find more posts on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 16, 2025, 07:27
May 16, 2025, 07:27
May 16, 2025, 07:14
May 16, 2025, 06:51
May 16, 2025, 06:38
May 16, 2025, 06:29
May 16, 2025, 06:24